|
|
Relief Therapeutics Holding SA / Key words: Personnel
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer
14Oct2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Announces Promotion of Paolo Ga... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Market Launch
Relief Announces U.S. Launch of PKU GOLIKE
10Oct2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Announces U.S. Launch of PKU GOLIKE®
Fir... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Miscellaneous
Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.
06Oct2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Announces Exclusive Distributor for PKU GOLIKE®... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Patent
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
03Oct2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Study
Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Childrens Hospital of Chicago
22Sep2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA / Key words: Interim Report
Relief Reports HalfYear 2022 Results and Provides Corporate Update
15Sep2022 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Reports HalfYear 2022 Results and Provides Corporate Upd... Lire le communiqué |
|
| |
|
| |
|
|
Relief Therapeutics Holding SA
/ Key words: Conference
Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
12.09.2022 / 07:05 CET/CEST
Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe ForumGeneva, Switzerland, September 12, 2022 – R... Lire le communiqué |
|
| |
|
| |
